Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arndt Hartmann

Showing results (241-250 of 975) with videos related to

Pageof 98
Sort By:
Journal of Biophotonics|October 4, 2017
Perspectives, potentials and trends of ex vivo and in vivo optical molecular pathologyChristoph Krafft, Ferdinand von Eggeling, Orlando Guntinas-Lichius, et al.
Human Pathology|January 24, 2006
Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analysesStefan Denzinger, Kristin Mohren, Ruth Knuechel, et al.
Oncology Reports|December 5, 2003
No evidence for mutation of B-RAF in urothelial carcinomas of the bladder and upper urinary tractRobert Stoehr, Anke Brinkmann, Thomas Filbeck, et al.
The American Journal of Surgical Pathology|May 9, 2018
Intraductal Papillary Mucinous Neoplasms of Minor Salivary Glands With AKT1 p.Glu17Lys MutationAbbas Agaimy, Sarina K Mueller, Klaus Bumm, et al.
Human Pathology|June 9, 2018
DICER1 mutation-positive giant botryoid fibroepithelial polyp of the urinary bladder mimicking embryonal rhabdomyosarcomaMarkus Eckstein, Abbas Agaimy, Joachim Woenckhaus, et al.
BJU International|August 17, 2010
The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancerWolfgang Otto, Stefan Denzinger, Hans-Martin Fritsche, et al.
Journal of Clinical Medicine|May 30, 2019
Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell CarcinomaAndreas Kahlmeyer, Christine G Stöhr, Arndt Hartmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCRMarcus Bettstetter, Stephan Dechant, Petra Ruemmele, et al.
Cancers|March 6, 2021
Tumour-Infiltrating Lymphocytes (TILs) and PD-L1 Expression Correlate with Lymph Node Metastasis, High-Grade Transformation and Shorter Metastasis-Free Survival in Patients with Acinic Cell Carcinoma (AciCC) of the Salivary GlandsSelina Hiss, Markus Eckstein, Patricia Segschneider, et al.
Experimental Cell Research|April 28, 2010
FGFR3 mutation affects cell growth, apoptosis and attachment in keratinocytesChristian Hafner, Erica Di Martino, Eva Pitt, et al.
Pageof 98

Showing results (241-250 of 975) with videos related to

Sort By:
Pageof 98
Journal of Biophotonics|October 4, 2017
Perspectives, potentials and trends of ex vivo and in vivo optical molecular pathologyChristoph Krafft, Ferdinand von Eggeling, Orlando Guntinas-Lichius, et al.
Human Pathology|January 24, 2006
Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analysesStefan Denzinger, Kristin Mohren, Ruth Knuechel, et al.
Oncology Reports|December 5, 2003
No evidence for mutation of B-RAF in urothelial carcinomas of the bladder and upper urinary tractRobert Stoehr, Anke Brinkmann, Thomas Filbeck, et al.
The American Journal of Surgical Pathology|May 9, 2018
Intraductal Papillary Mucinous Neoplasms of Minor Salivary Glands With AKT1 p.Glu17Lys MutationAbbas Agaimy, Sarina K Mueller, Klaus Bumm, et al.
Human Pathology|June 9, 2018
DICER1 mutation-positive giant botryoid fibroepithelial polyp of the urinary bladder mimicking embryonal rhabdomyosarcomaMarkus Eckstein, Abbas Agaimy, Joachim Woenckhaus, et al.
BJU International|August 17, 2010
The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancerWolfgang Otto, Stefan Denzinger, Hans-Martin Fritsche, et al.
Journal of Clinical Medicine|May 30, 2019
Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell CarcinomaAndreas Kahlmeyer, Christine G Stöhr, Arndt Hartmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCRMarcus Bettstetter, Stephan Dechant, Petra Ruemmele, et al.
Cancers|March 6, 2021
Tumour-Infiltrating Lymphocytes (TILs) and PD-L1 Expression Correlate with Lymph Node Metastasis, High-Grade Transformation and Shorter Metastasis-Free Survival in Patients with Acinic Cell Carcinoma (AciCC) of the Salivary GlandsSelina Hiss, Markus Eckstein, Patricia Segschneider, et al.
Experimental Cell Research|April 28, 2010
FGFR3 mutation affects cell growth, apoptosis and attachment in keratinocytesChristian Hafner, Erica Di Martino, Eva Pitt, et al.
Pageof 98